Nanotechnology research aimed at colorectal cancer receives $1.8 million in funding

Researchers received a $1.8 million grant from the National Cancer Institute to apply their nanotechnology expertise to more effectively deliver cancer drugs into tumor cells and combat cancer drug resistance.